Erythropoietin is involved in angiogenesis in human primary melanoma

Int J Exp Pathol. 2010 Dec;91(6):495-9. doi: 10.1111/j.1365-2613.2010.00731.x. Epub 2010 Aug 27.

Abstract

In this study, the extent of angiogenesis, evaluated as microvascular volume density, immunoreactivity of tumour cells to erythropoietin (Epo) and of endothelial cells to Epo receptor (EpoR) have been correlated in human primary melanoma specimens. Results showed that Epo/EpoR expression correlate with angiogenesis and tumour thickness. These findings suggest that Epo is secreted by tumour cells and it affects vascular endothelial cells via its receptor and promotes angiogenesis in a paracrine manner, playing an important role in melanoma angiogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Erythropoietin / metabolism*
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Melanoma / metabolism
  • Melanoma / pathology*
  • Middle Aged
  • Neovascularization, Pathologic / metabolism*
  • Neovascularization, Pathologic / pathology
  • Receptors, Erythropoietin / metabolism
  • Skin / metabolism*
  • Skin / pathology
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology*

Substances

  • Receptors, Erythropoietin
  • Erythropoietin